Navigation Links
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
Date:11/19/2012

ll The Company will host a conference call at 8:00 a.m. ET on Tuesday, November 20, 2012 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session.  Interested parties may access the audio webcast through the Company's IR website at http://ir.chinacordbloodcorp.com.  A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above.  Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 50728737.

About China Cord Blood CorporationChina Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.  For more information, please visit our website at http://www.chinacordbloodcorp.com.

Safe Harbor Statement This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or the Company's future financial performance. The Company has attempted to identify forward-looking statements by terminology including "anticipates", "believes", "expects", "can", "continue", "could", "estimates", "intends", "may", "plans", "potential", "predict", "should" or "will" or the negative of thes
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
2. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
3. China Biologic Products to Report Third Quarter 2012 Financial Results
4. Life Technologies New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
5. China Cord Blood Corporation and Golden Meditech Holdings Limited Enter into Convertible Note Financing to Further Expand Cord Blood Banking Services
6. Hawaii Tech Asia Takes Hawaii & US Entrepreneurs To China
7. Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018: China Market Research Reports
8. China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2013
9. China Cord Blood Corporation to Report First Quarter of Fiscal 2013 Financial Results
10. China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
11. China Biologic Reports Financial Results for the Second Quarter and First Half of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 Gene synthesis and bioengineering ... entered into a technology access and services agreement ... DNA2.0’s proprietary protein engineering technology, known as “ProteinGPS®” ... are extremely excited that the global leader ADM ... proprietary bioengineering technology has now been validated through ...
(Date:12/17/2014)... 16, 2014  Vermillion, Inc. (NASDAQ: VRML ... today announced the next step in its expanded strategy ... provider with the naming of current Chief Operating Officer, ... Officer, while current Chairman of the Board and CEO ... Chairman. These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
(Date:12/17/2014)...   Synageva BioPharma Corp. (NASDAQ: ... rare disorders, announced today its presentation at the upcoming ... San Francisco, CA. Sanj ... present on Monday, January 12, 2015, at 9:00 a.m. ... live and may be accessed from the "Webcasts & ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... -- Good computer security requires careful attention not just to ... to Debbie Christofferson, president of Sapphire Security Services . ... it open a crack, or are all your windows open? ... conference in Milwaukee . , ,Referring to the title of ...
... MADISON - Some of the first data from a new ... and by analogy galaxies in general - is making new ... , ,The findings from NASA's Spitzer Space Telescope were announced ... Edward Churchwell, a University of Wisconsin-Madison astronomer and the leader ...
... Sonic Foundry s Mediasite have a home ... help organizations capture presentations digitally and publish them on the ... for Mediasite, the companies announced in statements released in tandem ... can leverage the power of rich media communications without the ...
Cached Biology Technology:Expert says network security is about people, not just computers 2Milky Way churning out new stars at a furious pace 2Milky Way churning out new stars at a furious pace 3BxVideo designs Web hosting service for Sonic Foundry media presentations 2
(Date:12/17/2014)... Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home ... to their offering. ... different sensing technology than the iPhone 5S, Samsung ... in its product. The Galaxy S5 ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... DETROIT Diabetes Mellitus (DM), a metabolic disorder that ... chronic hyperglycemia that disrupts carbohydrate fat and protein metabolism ... both. DM can cause long-term damage, dysfunction and even ... may develop corneal complications and delayed wound healing. This ...
... Nuclear Magnetic Resonance (NMR) Spectroscopy is an extremely powerful ... by chemists from its origin, it is now essential ... scope extended in biological laboratories. Coupled with NMR, ... the enhancement of NMR signals from a wide range ...
... to five protective antigens, the presence of which are critical to ... been present in almost all isolates of Bordetella pertussis ... more than half of them, according to a paper published ahead ... "These findings tell us that there is an evolutionary advantage to ...
Cached Biology News:Wayne State discovers potential treatment for skin and corneal wound healing in diabetics 2A powder to enhance NMR signals 2Whooping cough vaccine antigen disappearing from bacteria in US 2
...
... contains the basic components required for the ... and recombinant rat Thymus Chemokine-1 in cell ... sufficient materials to run ELISAs on approximately ... conditions are met: The assay ...
Blimp-1 (H-150)...
Mouse Galectin-1 Affinity Purified Polyclonal Ab...
Biology Products: